Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human heterologous liver cells (for infusion)

EU orphan designation number: EU/3/06/362   
Active ingredient: Human heterologous liver cells (for infusion)
Indication: Treatment of acute liver failure
Sponsor: Promethera Biosciences
Watson & Crick Hill, 11 Rue Granbonpré, B-1435 Mont-Saint-Guibert, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/04/2006 Orphan designation EMEA/OD/037/05 (2006)1642 of 11/04/2006
20/06/2016 Transfer of orphan designation EMA/OD/037/05/T/01 (2016)3849 of 16/06/2016